Research on the Sun-Protective Capabilities of Super Glisodin
The sun gives out energy over a broad spectrum of wavelengths. Ultraviolet (UV) radiation, which has a shorter wavelength than either visible blue or violet light, is a cause of oxidative stress, and is responsible for skin irritation, sunburn and other adverse health effects. Many individuals are especially susceptible to the effects of sun exposure.
The study was conducted by French dermatologists over a 60 day period, 150 volunteers participated in this open trial. In the study, 86% of the participants experienced significant protection. The report concludes, “GliSODin usage prepares the skin for exposure to the sun and undeniably improves the condition of both the patient's skin and general condition.”
An early study on how Glisodin SOD helped protect sun-sensitive people was done in 2003 in France. Catherine Laverdet, M.D. conducted a pilot study with fifteen volunteers. Completed in September 2003, GliSODin demonstrated protection against skin irritation, sunburn and sun allergy.These findings led Dr. Laverdet and a team of 40 French dermatologists to evaluate the effects of GliSODin and sun exposure in 150 patients (130 women and 20 men) during a study designed to gauge the effect of GliSODin on individuals susceptible to flushing and burns, sun allergy, and other reactions such as pruritus, solar eczema and rashes.
GliSODin, a nutraceutical product that promotes the production of the body’s own antioxidants, including super oxide dismutase (SOD), has previously been shown in human research to promote cellular health and protect against damage caused by oxidative stress.
The patients were given 500mg of GliSODin a day 15 days prior to and during sun exposure. The patients sunbathed as usual and continued to use their regular sun screen (Index 20 to 100).
Enrolled patients were split into three different groups and evaluated after 60 days.
·Group 1: 75 patients who suffer flushes as soon as sun exposure begins or following more or less serious sunburns. In this group, 85% of the patients had no sunburn, 8% had diminished episodes, and 6% experienced sunburn
.Group 2: 60 patients who experience sun allergic reactions. In this group, 73% did not experience allergic reaction, 10% had a reduced reaction, and 16% experienced an allergic reaction
·Group 3: 15 patients with other reactions such as pruritus (severe skin itching), solar eczema and rashes. In this group, 100% of the patients were free from negative reactions
The participants also completed a questionnaire and reported the following:
·110 patients believed that their skin was well prepared for exposure to the sun ·76 patients reported that they tanned more with less exposure to the sun
·62 patients felt that taking GliSODin speeds up the tanning process
The patients were asked to report any quality of life issues that they associated with GliSODin usage. Eighty-eight patients declared their quality of life to have been improved, citing among other benefits, increased vitality, improved quality of sleep and alertness, and reduced muscular pain.